Citation
- Authors: Storci, G., Bertoni, S., De Carolis, S., Papi, A., Nati, M., Ceccarelli, C., Pirazzini, C., Garagnani, P., Ferrarini, A., Buson, G., Delledonne, M., Fiorentino, M., Capizzi, E., Gruppioni, E., Taffurelli, M., Santini, D., Franceschi, C., Bandini, G., Bonifazi, F., Bonafe, M.
- Year: 2013
- Journal: Am J Pathol 183 1688-1697
- Applications: in vitro / siRNA / jetPEI
- Cell type: MCF7
Description: Human breast adenocarcinoma cells
Known as: MCF-7, MCF 7
Abstract
Cancer stem cell survival relies on the activation of inflammatory pathways, which is speculatively triggered by cell autonomous mechanisms or by microenvironmental stimuli. Here, we observed that hypoxic bone marrow stroma-derived transforming growth factor-beta 1 promotes the growth of human breast cancer stem cells as mammospheres. The ensuing Slug-dependent serine 139 phosphorylation of the DNA damage sensor H2AX in breast cancer stem cells induces tumor necrosis factor-alpha and IL-8 mRNAs, whose stability is enhanced by cytoplasmic beta-catenin. beta-Catenin also up-regulates and binds miR-221, reducing the stability of the miR-221 targets Rad51 and ERalpha mRNAs. Our data show that the Slug/beta-catenin-dependent activation of DNA damage signaling triggered by the hypoxic microenvironment sustains the proinflammatory phenotype of breast cancer stem cells.